Please turn JavaScript on
supplysidesj icon

supplysidesj

We bring you the latest updates from Supplysidesj through a simple and fast subscription.

We can deliver your news in your inbox, on your phone or you can read them here on this website on your personal news page.

Unsubscribe at any time without hassle.

Supplysidesj's title: Just a moment...

Is this your feed? Claim it!

Publisher:  Unclaimed!
Message frequency:  0.8 / day

Message History

The debate over how long patients will use GLP-1 medications has real product implications. Experts say the honest answer is: We don't know yet, and assuming they’re temporary is a big mistake.

Read full story
FDA aims to modernize supplement oversight by leveraging technology, engaging industry and simplifying regulations.

Read full story
This edition of Supplement Shorts features a postbiotic for weight loss maintenance, insights from research reviews on common dietary supplement ingredients and executive updates at supplement industry companies.

Read full story
Entrepreneurs and investors are driving innovation in nutrition ingredients, exploring diverse opportunities for long-term growth.

Read full story
The National Advertising Review Board upheld the National Advertising Division’s recommendations that Tru Niagen discontinue use of its “clinically proven” claims. Niagen argued this goes against established precedent from the NAD and Federal Trade Commission.

Read full story